Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1963 1
1964 1
1965 6
1966 2
1967 17
1968 24
1969 25
1970 21
1971 15
1972 29
1973 37
1974 34
1975 38
1976 37
1977 31
1978 38
1979 27
1980 14
1981 17
1982 10
1983 19
1984 15
1985 11
1986 6
1987 7
1988 4
1989 7
1990 7
1991 7
1992 8
1993 10
1994 7
1995 2
1996 2
1997 12
1998 11
1999 10
2000 16
2001 31
2002 21
2003 34
2004 26
2005 22
2006 38
2007 34
2008 60
2009 45
2010 52
2011 66
2012 84
2013 96
2014 133
2015 132
2016 125
2017 86
2018 83
2019 108
2020 101
2021 125
2022 98
2023 84
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

2,109 results

Results by year

Filters applied: Free full text. Clear all
Page 1
Chinese guidelines on the management of endometrial hyperplasia.
Li L, Zhu L; Group for Chinese Guidelines On The Management Of Endometrial Hyperplasia. Li L, et al. Eur J Surg Oncol. 2024 Jul;50(7):108391. doi: 10.1016/j.ejso.2024.108391. Epub 2024 May 9. Eur J Surg Oncol. 2024. PMID: 38735237 Free article.
Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial.
Cooper KG, Bhattacharya S, Daniels JP, Horne AW, Clark TJ, Saridogan E, Cheed V, Pirie D, Melyda M, Monahan M, Roberts TE, Cox E, Stubbs C, Middleton LJ; PRE-EMPT Collaborative Group. Cooper KG, et al. BMJ. 2024 May 15;385:e079006. doi: 10.1136/bmj-2023-079006. BMJ. 2024. PMID: 38749550 Free PMC article. Clinical Trial.
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial.
Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro TD, Baeten JM; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Hofmeyr GJ, et al. PLoS One. 2024 May 9;19(5):e0299802. doi: 10.1371/journal.pone.0299802. eCollection 2024. PLoS One. 2024. PMID: 38722832 Free PMC article. Clinical Trial.
A 52-mg levonorgestrel-releasing intrauterine system vs bipolar radiofrequency nonresectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multicenter randomized controlled trial.
Huijs DPC, Derickx AJM, Beelen P, Leemans JC, van Kuijk SMJ, Bongers MY, Geomini PMAJ. Huijs DPC, et al. Am J Obstet Gynecol. 2024 May;230(5):542.e1-542.e10. doi: 10.1016/j.ajog.2024.01.016. Epub 2024 Jan 26. Am J Obstet Gynecol. 2024. PMID: 38280433 Free article. Clinical Trial.
Comparing the efficacy and pregnancy outcome of intrauterine balloon and intrauterine contraceptive device in the prevention of adhesion reformation after hysteroscopic adhesiolysis in infertile women: a prospective, randomized, controlled trial study.
Ding H, Zhang H, Qiao R, Sun N, Ji Y, Pang W, Li W, Zhang Q. Ding H, et al. Reprod Biol Endocrinol. 2024 Apr 23;22(1):49. doi: 10.1186/s12958-024-01222-w. Reprod Biol Endocrinol. 2024. PMID: 38654308 Free PMC article. Clinical Trial.
Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
Hofmeyr GJ, Singata-Madliki M, Batting J, Balakrishna Y, Morroni C. Hofmeyr GJ, et al. BMC Womens Health. 2024 Mar 8;24(1):167. doi: 10.1186/s12905-024-02990-8. BMC Womens Health. 2024. PMID: 38459552 Free PMC article. Clinical Trial.
One-year follow up of contraceptive use and pregnancy rates after early medical abortion: Secondary outcomes from a randomized controlled trial of immediate post-abortion placement of intrauterine devices.
Hogmark S, Envall N, Gemzell-Danielsson K, Kopp Kallner H. Hogmark S, et al. Acta Obstet Gynecol Scand. 2023 Dec;102(12):1694-1702. doi: 10.1111/aogs.14662. Epub 2023 Aug 23. Acta Obstet Gynecol Scand. 2023. PMID: 37614066 Free PMC article. Clinical Trial.
Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD.
Gupta PM, Balle C, Tharp GK, Nelson SA, Gasper MA, Brown B, Alisoltani A, Onono M, Palanee-Phillips T, Nair G, Ayele H, Noel-Romas L, Passmore JS, Burgener AD, Heffron R, Jaspan HB, Bosinger SE. Gupta PM, et al. Clin Immunol. 2023 Oct;255:109750. doi: 10.1016/j.clim.2023.109750. Epub 2023 Sep 3. Clin Immunol. 2023. PMID: 37660744 Free PMC article. Clinical Trial.
Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices.
Fassett MJ, Reed SD, Rothman KJ, Pisa F, Schoendorf J, Wahdan Y, Peipert JF, Gatz J, Ritchey ME, Armstrong MA, Raine-Bennett T, Postlethwaite D, Getahun D, Shi JM, Xie F, Chiu VY, Im TM, Takhar HS, Wang J, Anthony MS. Fassett MJ, et al. Obstet Gynecol. 2023 Sep 1;142(3):641-651. doi: 10.1097/AOG.0000000000005299. Epub 2023 Aug 3. Obstet Gynecol. 2023. PMID: 37535968 Free PMC article.
Conventional manual technique of post placental IUD insertion versus intra-cesarean post placental introducer withdrawal IUD insertion technique: a new standardized technique for IUD insertion during cesarean section: a randomized controlled trial.
Seleem M, Sedik MM, Megahed AMM, Nabil H. Seleem M, et al. BMC Pregnancy Childbirth. 2023 Jun 26;23(1):474. doi: 10.1186/s12884-023-05777-1. BMC Pregnancy Childbirth. 2023. PMID: 37365489 Free PMC article. Clinical Trial.
Comparing levonorgestrel intrauterine system with hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open-label, controlled trial.
Zhang J, Zhu C, Yan L, Wang Y, Zhu Q, He C, He X, Ji S, Tian Y, Xie L, Liang Y, Xia W, Mol BW, Huirne JAF. Zhang J, et al. Am J Obstet Gynecol. 2023 Jun;228(6):712.e1-712.e16. doi: 10.1016/j.ajog.2023.03.020. Epub 2023 Mar 17. Am J Obstet Gynecol. 2023. PMID: 36935068 Free article. Clinical Trial.
Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China.
Che Y, Hou GF, Zhang HP, Yang H, Lin SJ, Gan T, Yang WH, Shi CH, Ren WJ, Xu YQ, Yin BM, Chen TT, Gan YJ, Zhang Y, Zhang Y, Cheng LN. Che Y, et al. Contraception. 2023 Jun;122:109999. doi: 10.1016/j.contraception.2023.109999. Epub 2023 Feb 26. Contraception. 2023. PMID: 36849032 Free article.
Contraceptive Continuation and Experiences Obtaining Implant and IUD Removal Among Women Randomized to Use Injectable Contraception, Levonorgestrel Implant, and Copper IUD in South Africa and Zambia.
Cartwright AF, Callahan RL, Beksinska M, Kasaro MP, Tang JH, Milford C, Wong C, Velarde M, Maphumulo V, Fawzy M, Chinyama M, Chabu E, Mudenda M, Smit J. Cartwright AF, et al. Stud Fam Plann. 2023 Jun;54(2):379-401. doi: 10.1111/sifp.12222. Epub 2023 Feb 1. Stud Fam Plann. 2023. PMID: 36727169 Free PMC article. Clinical Trial.
Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial.
Deese J, Chen PL, Gao X, Heffron R, Hobbs M, Lapple D, Jaspan H, Miller A, Nair G, Onono M, Palanee-Phillips T, Reddy K, Steiner MJ. Deese J, et al. AIDS Behav. 2023 Mar;27(3):978-983. doi: 10.1007/s10461-022-03834-y. Epub 2022 Nov 11. AIDS Behav. 2023. PMID: 36357806 Free PMC article. Clinical Trial.
Intrauterine devices for menorrhagia.
Potter J, Lindblad AJ. Potter J, et al. Can Fam Physician. 2023 Feb;69(2):113. doi: 10.46747/cfp.6902113. Can Fam Physician. 2023. PMID: 36813509 Free PMC article. No abstract available.
Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial.
Brown BP, Feng C, Tanko RF, Jaumdally SZ, Bunjun R, Dabee S, Happel AU, Gasper M, Nyangahu DD, Onono M, Nair G, Palanee-Phillips T, Scoville CW, Heller K, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Heffron R, Jaspan HB. Brown BP, et al. Nat Commun. 2023 Jan 30;14(1):499. doi: 10.1038/s41467-023-36002-4. Nat Commun. 2023. PMID: 36717556 Free PMC article. Clinical Trial.
Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year experience in one tertiary hospital in China.
Yin J, Li Y, Wang H, Wang W, Gu Y, Jin Y, Deng C, Pan L. Yin J, et al. Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:83-88. doi: 10.1016/j.ejogrb.2022.11.009. Epub 2022 Nov 11. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 36436458 Free article.
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia.
Chen J, Cao D, Yang J, Yu M, Zhou H, Cheng N, Wang J, Zhang Y, Peng P, Shen K. Chen J, et al. Int J Gynecol Cancer. 2022 Dec 5;32(12):1561-1567. doi: 10.1136/ijgc-2022-003882. Int J Gynecol Cancer. 2022. PMID: 36368706 Free PMC article.
Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
Anthony MS, Zhou X, Schoendorf J, Reed SD, Getahun D, Armstrong MA, Gatz J, Peipert JF, Raine-Bennett T, Fassett MJ, Saltus CW, Ritchey ME, Ichikawa L, Shi JM, Alabaster A, Wahdan Y, Wang J, Xie F, Merchant M, Hunter S, Chiu VY, Postlethwaite D, Rothman KJ, Im TM, Chillemi G, Takhar HS, Asiimwe A, Pisa F. Anthony MS, et al. Obstet Gynecol. 2022 Dec 1;140(6):1017-1030. doi: 10.1097/AOG.0000000000005000. Epub 2022 Nov 2. Obstet Gynecol. 2022. PMID: 36357958 Free PMC article. Clinical Trial.
What Have We Learned? Implementation of a Shared Learning Agenda and Access Strategy for the Hormonal Intrauterine Device.
Rademacher KH, Sripipatana T, Danna K, Sitrin D, Brunie A, Williams KM, Afolabi K, Rasoanirina F, Ramarao S, Pfitzer A, Cain D, Simon M, Menotti E, Hazelwood A, Nwala AA, Saidu Z, Chowdhury R, Taiwo A, Chidanyika A, Ndirangu G, Steiner MJ, Lepine MC, Homan R, Saad A, Vivalo J, Dorflinger LJ. Rademacher KH, et al. Glob Health Sci Pract. 2022 Oct 31;10(5):e2100789. doi: 10.9745/GHSP-D-21-00789. Print 2022 Oct 31. Glob Health Sci Pract. 2022. PMID: 36316136 Free PMC article.
Hysteroscopic removal of intrauterine device in early pregnancy.
Stabile G, Godina C, Cracco F, Mangino FP, Canton M, Romano F, Ricci G. Stabile G, et al. BMC Womens Health. 2022 Oct 27;22(1):425. doi: 10.1186/s12905-022-02012-5. BMC Womens Health. 2022. PMID: 36303205 Free PMC article.
The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant.
Tanko RF, Bunjun R, Dabee S, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Harryparsad R, Happel AU, Gamieldien H, Qumbelo Y, Sinkala M, Scoville CW, Heller K, Baeten JM, Bosinger SE, Burgener A, Heffron R, Jaspan HB, Passmore JAS. Tanko RF, et al. J Infect Dis. 2022 Sep 13;226(5):907-919. doi: 10.1093/infdis/jiac084. J Infect Dis. 2022. PMID: 35263421 Free PMC article. Clinical Trial.
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.
Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Mugo NR, et al. Clin Infect Dis. 2022 Sep 10;75(4):586-595. doi: 10.1093/cid/ciab1027. Clin Infect Dis. 2022. PMID: 34910143 Free PMC article. Clinical Trial.
[An update in intrauterine contraception].
Mawet M, Chabbert Buffet N, Gerard M, Nisolle M, Kridelka F, Pintiaux A. Mawet M, et al. Rev Med Liege. 2022 Sep;77(9):521-526. Rev Med Liege. 2022. PMID: 36082599 Free article. French.
Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.
Khalighi M, Wheeler AP, Adeyemi-Fowode OA, Kouides PA, Durazo-Arvizu RA, Haley K, Dersch CM, Weyand AC, Baldwin MK, Borzutzky C. Khalighi M, et al. J Adolesc Health. 2022 Aug;71(2):204-209. doi: 10.1016/j.jadohealth.2022.02.018. Epub 2022 Apr 13. J Adolesc Health. 2022. PMID: 35430143 Free PMC article.
Genital inflammatory status and the innate immune response to contraceptive initiation.
Radzey N, Harryparsad R, Meyer B, Chen PL, Gao X, Morrison C, Taku O, Williamson AL, Mehou-Loko C, Lefebvre d'Hellencourt F, Buck G, Smit J, Strauss J, Nanda K, Ahmed K, Beksinska M, Serrano M, Bailey V, Masson L, Deese J. Radzey N, et al. Am J Reprod Immunol. 2022 Aug;88(2):e13542. doi: 10.1111/aji.13542. Epub 2022 Apr 20. Am J Reprod Immunol. 2022. PMID: 35394678 Free PMC article. Clinical Trial.
Contraception e-learning for medical students.
Douglass KM, Niino C, Bryan K, Kwan L, Sridhar A. Douglass KM, et al. BMJ Sex Reprod Health. 2022 Jul;48(3):231-232. doi: 10.1136/bmjsrh-2021-201401. Epub 2021 Dec 23. BMJ Sex Reprod Health. 2022. PMID: 34949689 Free article. No abstract available.
Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
Oderkerk TJ, Beelen P, Geomini PMAJ, Herman MC, Leemans JC, Duijnhoven RG, Bosmans JE, Pannekoek JN, Clark TJ, Mol BWJ, Bongers MY. Oderkerk TJ, et al. BMC Womens Health. 2022 Jun 27;22(1):257. doi: 10.1186/s12905-022-01843-6. BMC Womens Health. 2022. PMID: 35761328 Free PMC article.
Missing strings following immediate postpartum IUD placement.
Henkel A, Blumenthal PD. Henkel A, et al. BMJ Sex Reprod Health. 2022 Apr;48(2):152-155. doi: 10.1136/bmjsrh-2021-201400. Epub 2022 Mar 11. BMJ Sex Reprod Health. 2022. PMID: 35277465 Free article. No abstract available.
Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
Beesham I, Bosman S, Beksinska M, Scoville CW, Smit J, Nanda K. Beesham I, et al. Contraception. 2022 Apr;108:37-43. doi: 10.1016/j.contraception.2021.11.002. Epub 2021 Nov 27. Contraception. 2022. PMID: 34848180 Free article. Clinical Trial.
Association of the Timing of Postpartum Intrauterine Device Insertion and Breastfeeding With Risks of Intrauterine Device Expulsion.
Armstrong MA, Raine-Bennett T, Reed SD, Gatz J, Getahun D, Schoendorf J, Postlethwaite D, Fassett MJ, Peipert JF, Saltus CW, Merchant M, Alabaster A, Zhou X, Ichikawa L, Shi JM, Chiu VY, Xie F, Hunter S, Wang J, Ritchey ME, Chillemi G, Im TM, Takhar HS, Pisa F, Asiimwe A, Anthony MS. Armstrong MA, et al. JAMA Netw Open. 2022 Feb 1;5(2):e2148474. doi: 10.1001/jamanetworkopen.2021.48474. JAMA Netw Open. 2022. PMID: 35226086 Free PMC article.
Adenomyosis.
[No authors listed] [No authors listed] Am Fam Physician. 2022 Jan 1;105(1):Online. Am Fam Physician. 2022. PMID: 35029958 Free article. No abstract available.
Adenomyosis: Diagnosis and Management.
Schrager S, Yogendran L, Marquez CM, Sadowski EA. Schrager S, et al. Am Fam Physician. 2022 Jan 1;105(1):33-38. Am Fam Physician. 2022. PMID: 35029928 Free article.
Complications after interval postpartum intrauterine device insertion.
Ramos-Rivera M, Averbach S, Selvaduray P, Gibson A, Ngo LL. Ramos-Rivera M, et al. Am J Obstet Gynecol. 2022 Jan;226(1):95.e1-95.e8. doi: 10.1016/j.ajog.2021.08.028. Epub 2021 Aug 28. Am J Obstet Gynecol. 2022. PMID: 34461075 Free PMC article.
Changing US trends in contraceptive choices.
Vegunta S, Carrubba AR, Wasson MN. Vegunta S, et al. Cleve Clin J Med. 2021 Dec 2;88(12):689-695. doi: 10.3949/ccjm.88a.20110. Cleve Clin J Med. 2021. PMID: 34857607 Free article.
2,109 results